Successful restoration of corneal surface integrity with a tissue-engineered allogeneic implant in severe keratitis patients.

[1]  M. Zeppieri,et al.  An Overview of Corneal Transplantation in the Past Decade , 2023, Clinics and practice.

[2]  G. Lichtner,et al.  Systematic Review and Meta-Analysis: Outcomes after Descemet membrane endothelial keratoplasty vs ultrathin Descemet stripping automated endothelial keratoplasty. , 2022, American journal of ophthalmology.

[3]  P. Prabhasawat,et al.  Comparison of epitheliotrophic factors in platelet-rich plasma versus autologous serum and their treatment efficacy in dry eye disease , 2022, Scientific Reports.

[4]  P. Labarre,et al.  In situ Tissue Regeneration in the Cornea from Bench to Bedside , 2021, Cells Tissues Organs.

[5]  S. Valente,et al.  Impact of blood source and component manufacturing on neurotrophin content and in vitro cell wound healing. , 2021, Blood transfusion = Trasfusione del sangue.

[6]  J. Alió,et al.  Corneal Stromal Regeneration Therapy for Advanced Keratoconus: Long-term Outcomes at 3 Years , 2021, Cornea.

[7]  H. Nosrati,et al.  Stem cell-based therapeutic strategies for corneal epithelium regeneration. , 2020, Tissue & cell.

[8]  V. Romano,et al.  Persistent loss of marginal corneal arcades after chemical injury , 2020, Indian journal of ophthalmology.

[9]  Miguel Angel Martin-Piedra,et al.  Long-Term in vivo Evaluation of Orthotypical and Heterotypical Bioengineered Human Corneas , 2020, Frontiers in Bioengineering and Biotechnology.

[10]  E. Alarcon,et al.  Biosynthetic alternatives for corneal transplant surgery , 2020 .

[11]  S. Shukla,et al.  Limbal Epithelial and Mesenchymal Stem Cell Therapy for Corneal Regeneration , 2019, Current eye research.

[12]  R. Oruezabal,et al.  Successful development and clinical translation of a novel anterior lamellar artificial cornea , 2019, Journal of tissue engineering and regenerative medicine.

[13]  Dina B. Abusamra,et al.  Galectin-3 initiates epithelial-stromal paracrine signaling to shape the proteolytic microenvironment during corneal repair , 2019, Science Signaling.

[14]  J. Chodosh,et al.  Autologous limbal stem cell transplantation: a systematic review of clinical outcomes with different surgical techniques , 2019, British Journal of Ophthalmology.

[15]  S. Heegaard,et al.  A presentation of culture-positive corneal donors and the effect on clinical outcomes , 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.

[16]  S. Ferrari,et al.  Simple limbal epithelial transplantation: a review on current approach and future directions. , 2018, Survey of ophthalmology.

[17]  M. Armant,et al.  Cultivated Autologous Limbal Epithelial Cell Transplantation: New Frontier in the Treatment of Limbal Stem Cell Deficiency. , 2018, American journal of ophthalmology.

[18]  Chaoliang He,et al.  Biomaterials-enabled cornea regeneration in patients at high risk for rejection of donor tissue transplantation , 2018, npj Regenerative Medicine.

[19]  Graziella Pellegrini,et al.  Navigating Market Authorization: The Path Holoclar Took to Become the First Stem Cell Product Approved in the European Union , 2017, Stem cells translational medicine.

[20]  P. Reinke,et al.  Accelerating Patients’ Access to Advanced Therapies in the EU , 2017, Molecular therapy. Methods & clinical development.

[21]  S. Arias-Santiago,et al.  A study protocol for a multicentre randomised clinical trial evaluating the safety and feasibility of a bioengineered human allogeneic nanostructured anterior cornea in patients with advanced corneal trophic ulcers refractory to conventional treatment , 2017, BMJ Open.

[22]  Gilles Thuret,et al.  Global Survey of Corneal Transplantation and Eye Banking. , 2016, JAMA ophthalmology.

[23]  M. Harissi-Dagher,et al.  The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure , 2015, British Journal of Ophthalmology.

[24]  M. Griffith,et al.  Bioengineered Corneas Grafted as Alternatives to Human Donor Corneas in Three High‐Risk Patients , 2015, Clinical and translational science.

[25]  Isabelle Brunette,et al.  Stable corneal regeneration four years after implantation of a cell-free recombinant human collagen scaffold. , 2014, Biomaterials.

[26]  N. Cuende.  Andalusian Initiative for Advanced Therapies: Fostering Synergies , 2013, Stem cells translational medicine.

[27]  M. S. Cortina,et al.  Visual Outcomes of Boston Keratoprosthesis Implantation as the Primary Penetrating Corneal Procedure , 2012, Cornea.

[28]  Manoj Gulati,et al.  Turning the tide of corneal blindness , 2012, Indian journal of ophthalmology.

[29]  M. M. Pérez,et al.  Transparency in a Fibrin and Fibrin–Agarose Corneal Stroma Substitute Generated by Tissue Engineering , 2011, Cornea.

[30]  R. Ghinea,et al.  Investigating a novel nanostructured fibrin-agarose biomaterial for human cornea tissue engineering: rheological properties. , 2011, Journal of the mechanical behavior of biomedical materials.

[31]  Rejean Munger,et al.  A Biosynthetic Alternative to Human Donor Tissue for Inducing Corneal Regeneration: 24-Month Follow-Up of a Phase 1 Clinical Study , 2010, Science Translational Medicine.

[32]  G. Pellegrini,et al.  Limbal stem-cell therapy and long-term corneal regeneration. , 2010, The New England journal of medicine.

[33]  A. Izeta,et al.  Clinical translation of stem cell therapies: a bridgeable gap. , 2010, Cell stem cell.

[34]  C. Shiboski,et al.  A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren's Syndrome International Registry. , 2010, American journal of ophthalmology.

[35]  N. Sharma,et al.  Use of tissue adhesives in ophthalmology , 2009, Indian Journal of Ophthalmology.

[36]  C. Baudouin,et al.  Direct epithelial–stromal interaction in corneal wound healing: Role of EMMPRIN/CD147 in MMPs induction and beyond , 2009, Progress in Retinal and Eye Research.

[37]  K. Tsubota,et al.  New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. , 2007, Ophthalmology.

[38]  Miguel Alaminos,et al.  Construction of a complete rabbit cornea substitute using a fibrin-agarose scaffold. , 2006, Investigative ophthalmology & visual science.

[39]  J. Chodosh,et al.  Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation. , 2017, Ophthalmology.

[40]  Sueko M Ng,et al.  Boston Type 1 Keratoprosthesis versus Repeat Donor Keratoplasty for Corneal Graft Failure: A Systematic Review and Meta-analysis. , 2016, Ophthalmology.